Healthcare provider profile · identity verified

William Claude Bird, MD

Family Practice · PRINCETON, WV · NPI 1033108733

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	127	20
Gabapentin	Gabapentin	126	18
Furosemide	Furosemide	122	26
Potassium Chloride	Potassium Chloride	102	14
Amlodipine Besylate	Amlodipine Besylate	95	11
Eliquis	Apixaban	94	16
Quetiapine Fumarate	Quetiapine Fumarate	93	16
Memantine Hcl	Memantine Hcl	89	15
Atorvastatin Calcium	Atorvastatin Calcium	76	13
Trazodone Hcl	Trazodone Hcl	72	11
Donepezil Hcl	Donepezil Hcl	68	suppressed
Lorazepam	Lorazepam	68	15
Pantoprazole Sodium	Pantoprazole Sodium	66	15
Buspirone Hcl	Buspirone Hcl	65	11
Divalproex Sodium	Divalproex Sodium	65	suppressed
Metoprolol Succinate	Metoprolol Succinate	64	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	11
Lisinopril	Lisinopril	56	14
Famotidine	Famotidine	50	suppressed
Montelukast Sodium	Montelukast Sodium	50	suppressed
Simvastatin	Simvastatin	40	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	39	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	38	suppressed
Duloxetine Hcl	Duloxetine Hcl	37	suppressed
Warfarin Sodium	Warfarin Sodium	34	suppressed
Azithromycin	Azithromycin	32	23
Mirtazapine	Mirtazapine	32	suppressed
Sertraline Hcl	Sertraline Hcl	32	suppressed
Atenolol	Atenolol	31	suppressed
Levofloxacin	Levofloxacin	31	22
Ondansetron Hcl	Ondansetron Hcl	31	22
Cyproheptadine Hcl	Cyproheptadine Hcl	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Omeprazole	Omeprazole	30	suppressed
Alprazolam	Alprazolam	27	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	suppressed
Fluconazole	Fluconazole	25	17
Spironolactone	Spironolactone	25	suppressed
Methocarbamol	Methocarbamol	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Megestrol Acetate	Megestrol Acetate	22	suppressed
Nystatin	Nystatin	21	suppressed
Prednisone	Prednisone	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Losartan Potassium	Losartan Potassium	20	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	19	suppressed
Metformin Hcl	Metformin Hcl	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Diazepam	Diazepam	18	suppressed
Methenamine Hippurate	Methenamine Hippurate	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	17	11
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	15	suppressed
Torsemide	Torsemide	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Digoxin	Digoxin	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Modafinil	Modafinil	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Clonazepam	Clonazepam	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Glipizide	Glipizide	12	suppressed
Loperamide	Loperamide Hcl	12	12
Memantine Hcl Er	Memantine Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	11	suppressed
Trimethoprim	Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error